| Relevant gene in stock |
Fly disease model or related mutation or transgene |
Stk # |
Comments |
| Fly aph-1 stocks |
| aph-1 |
P{TRiP.HMS01693}attP40 |
38249 |
Expresses dsRNA for RNAi of aph-1 (FBgn0031458) under the control of UAS. |
| aph-1 |
aph-1[D35] |
3917 |
Amino acid replacement R99 results in truncation of the aph-1 protein between transmembrane domains 3 and 4. |
| aph-1 |
aph-1[D35] |
63242 |
Amino acid replacement R99 results in truncation of the aph-1 protein between transmembrane domains 3 and 4. |
| aph-1 |
aph-1[D35] |
63244 |
Amino acid replacement R99 results in truncation of the aph-1 protein between transmembrane domains 3 and 4. |
| aph-1 |
P{UAS-aph-1.V5}3 |
63217 |
Expresses V5-tagged aph-1 under the control of UAS. |
| aph-1 |
P{UAS-aph-1.V5}2 |
63216 |
Expresses V5-tagged aph-1 under the control of UAS. |
| Stocks carrying human APP |
| APP (human) |
P{UAS-hAPP.Z.Z}attP40 |
64384 |
Expresses human APP under UAS control. |
| APP (human) |
P{UAS-hAPP.HA}attP40 |
64385 |
Expresses human APP protein with a C-terminal HA tag under UAS control. |
| APP (human) |
P{UAS-APP695-N-myc}TW6 |
6700 |
Expresses human amyloid precursor protein with an amino terminal myc tag under UAS control. |
| APP (human) |
P{UAS-APP.YFP}LG |
32039 |
Expresses YFP-tagged human APP under the control of UAS. |
| APP (human) |
P{UAS-APP.695.Exel}5 |
33795 |
Expresses the 695 amino acid isoform of human APP under the control of UAS. |
| APP (human) |
P{UAS-APP.695.Exel}3 |
33796 |
Expresses the 695 amino acid isoform of human APP under the control of UAS. |
| APP (human) |
PBac{UAS-Abeta.1-40}VK00033 |
64215 |
Expresses human Abeta amino acids 1-40 under the control of UAS. |
| APP (human) |
PBac{UAS-Abeta.1-42}VK00033 |
64216 |
Expresses human Abeta amino acids 1-42 under the control of UAS. |
| APP - Dutch |
P{UAS-APP.695.E693Q.Exel}9 |
33790 |
Expresses the 695 amino acid isoform of human APP carrying the familial Alzheimer's 'Dutch' mutation (E693Q - amino acid numbering based on APP sequence) under the control of UAS. |
| APP - Dutch |
P{UAS-APP.695.E693Q.Exel}5 |
33789 |
Expresses the 695 amino acid isoform of human APP carrying the familial Alzheimer's 'Dutch' mutation (E693Q - amino acid numbering based on APP sequence) under the control of UAS. |
| APP - Dutch and French |
P{UAS-APP.770.E693Q.V715M.myc.VTR}4 |
33791 |
Expresses the 770 amino acid isoform of human APP carrying the familial Alzheimer's 'Dutch' (E693Q) and 'French' (V715M) mutations (amino acid numbering based on APP sequence) under the control of UAS. |
| APP - Dutch and German |
P{UAS-APP.770.E693Q.V715A.myc.VTR}3 |
33792 |
Expresses the 770 amino acid isoform of human APP carrying the familial Alzheimer's 'Dutch' (E693Q) and 'German' (V715A) mutations (amino acid numbering based on APP sequence) under the control of UAS. |
| APP - London |
P{UAS-APP.V717F.LOND}LG |
32036 |
Expresses human APP carrying the London mutation (V717F) under the control of UAS. |
| APP - Swedish |
P{UAS-APP695-Swedish-N-myc}TS23 |
6701 |
Expresses human amyloid precursor protein with familial Alzheimer mutations and an amino terminal myc tag under UAS control. |
| APP - Swedish |
P{UAS-APP.770.K670N.M671L.VTR}3 |
33793 |
Expresses the 770 amino acid isoform of human APP carrying the familial Alzheimer's 'Swedish' mutation (K670N and M671L - amino acid numbering based on APP sequence) under the control of UAS. |
| APP - Swedish |
P{UAS-APP.770.K670N.M671L.E693G.VTR}7 |
33794 |
Expresses the 770 amino acid isoform of human APP carrying the familial Alzheimer's 'Swedish' (K670N, M671L) and 'Arctic' (E693G) mutations (amino acid numbering based on APP sequence) under the control of UAS. |
| APP - BASS mutant |
P{UAS-HsapAPP.DeltaBASS}2 |
29872 |
UAS sequences control expression of human APP deleted for part of the basolateral sorting signal (amino acids 652 - 656, QYTSI) and tagged N-terminally with myc. |
| APP - ECD mutant |
P{UAS-APP.695SPA4CT.T:Myc}XX |
6702 |
Expresses human amyloid precursor protein with a carboxy terminal myc tag and lacking most of the extracellular domain under UAS control. |
| APP - Go mutant |
P{UAS-HsapAPP.DeltaGo}3 |
29873 |
UAS sequences control expression of human APP deleted for the Go binding site (amino acids 657 - 668, HHGVVEVDAAV) and tagged N-terminally with myc. |
| APP - ICD mutant |
P{UAS-HsapAPP.DeltaICD}3 |
29875 |
UAS sequences control expression of human APP with EGFP in place of the intracellular domain and tagged N-terminally with myc. |
| APP - ICD mutant |
P{UAS-HsapAPP.DeltaICD}2 (2 copies) |
29876 |
UAS sequences control expression of human APP with EGFP in place of the intracellular domain and tagged N-terminally with myc. |
| APP - ICD mutant |
P{UAS-APP.695DeltaCT.T:Myc}61 |
6703 |
Expresses human amyloid precursor protein with a truncated carboxy terminus and an amino terminal myc tag under UAS control. |
| APP - NPTY mutant |
P{UAS-HsapAPP.DeltaNPTY}3c |
29868 |
UAS sequences control expression of human APP deleted for the NPTY internalization sequence and tagged N-terminally with myc. |
| APP - NPTY mutant |
P{UAS-HsapAPP.DeltaNPTY}3 (2 copies) |
29869 |
UAS sequences control expression of human APP deleted for the NPTY internalization sequence and tagged N-terminally with myc. |
| APP - PEER mtuant |
P{UAS-HsapAPP.DeltaPEER}3 |
29874 |
UAS sequences control expression of human APP deleted for amino acids 670 - 679 (PEERHLSKMQ) and tagged N-terminally with myc. |
| APP - mutant |
P{UAS-APP.M596I.F615P}2 |
30092 |
Expresses human APP, with two amino acid changes designed to reduce cleavage by alpha secretase (M596I and F615P), under UAS control. |
| APP - N684A |
P{UAS-HsapAPP.N684A}2 |
29871 |
UAS sequences control expression of human APP with the amino acid change N684A and tagged N-terminally with myc. |
| APP - Y682A |
P{UAS-HsapAPP.Y682A}2 |
29870 |
UAS sequences control expression of human APP with the amino acid change Y682A and tagged N-terminally with myc. |
| APP/APLP2 |
P{UAS-HsapAPLP2::HsapAPP.T:Myc}2 |
30123 |
Expresses a myc-tagged fusion of human APP and APLP2 under UAS control. |
| APP-based g-secretase reporter |
P{GMR-APP-GAL4}2 |
52016 |
Expresses a reporter for gamma-secretase activity under GMR control consisting of the human APP transmembrane domain and gamma-secretase cleavage site fused to GAL4. |
| APP - LV fusion |
P{UAS-mycAPP.LV}3 |
30120 |
Expresses myc-tagged human APP fused C-terminally to LV (LexA DNA binding domain fused to the transcriptional activator VP16) under UAS control. |
| APP - LV fusion |
P{UAS-mycAPP.LV}2 |
30119 |
Expresses myc-tagged human APP fused C-terminally to LV (LexA DNA binding domain fused to the transcriptional activator VP16) under UAS control. |
| APP - LV fusion |
P{UAS-alphaAPP.LV}3 |
29949 |
UAS drives expression of truncated human APP (signal peptide fused to the alpha-secretase cleavage site) fused C-terminally to LexA-VP16. |
| APP and BACE1 |
P{UAS-BACE1.Exel}7b, P{UAS-APP.695.Exel}1 |
33797 |
Expresses human BACE1 and the 695 amino acid isoform of human APP under the control of UAS. Homozygotes may be present. |
| APP and BACE1 |
P{UAS-APP695-N-myc}TW6, P{UAS-BACE1.Exel}1b |
33798 |
Expresses human BACE1 and an N-terminally myc-tagged 695 amino acid isoform of human APP under the control of UAS. |
| APP and tau |
P{UAS-APP.C99.myc.Exel}21, P{UAS-MAPT.VTR}31K |
33803 |
Expresses the C99 fragment of APP with the human APP signal peptide and a C-terminal myc tag and human MAPT (tau) under UAS control. |
| APP and tau |
P{UAS-APP.C99.myc.Exel}19, P{UAS-MAPT.VTR}12B |
33801 |
Expresses the C99 fragment of APP with the human APP signal peptide and a C-terminal myc tag and human MAPT (tau) under UAS control. |
| APP and tau |
P{UAS-APP.695.Exel}3, P{UAS-MAPT.VTR}31K |
33802 |
Expresses human MAPT (tau) and the 695 amino acid isoform of human APP under the control of UAS, VTR. |
| APP, BACE1 and tau |
P{UAS-MAPT.VTR}54, P{UAS-APP.695.Exel}3, P{UAS-BACE1.Exel}9a |
33799 |
Expresses human MAPT (tau), human BACE1, and the 695 amino acid isoform of human APP under the control of UAS. |
| APP, BACE1 and tau |
P{UAS-APP.695.Exel}3, P{UAS-BACE1.Exel}9a, P{UAS-MAPT.VTR}31 |
33800 |
Expresses human MAPT (tau), human BACE1, and the 695 amino acid isoform of human APP under the control of UAS. |
| Stocks carrying the C99 fragment of human APP |
| APP/C99 |
P{UAS-SPA4CT.LV}3 |
29854 |
Expresses human APP lacking the N-terminal extracellular domain and fused at its C-terminus to nls2, plus amino acids 2-87 of lexA and amino acids 410-489 of VP16. The product of this construct is intended to mimic the BACE1 cleaved protein isoform of APP |
| APP/C99 |
P{UAS-SPA4CT.LV}2 |
29853 |
Expresses human APP lacking the N-terminal extracellular domain and fused at its C-terminus to nls2, plus amino acids 2-87 of lexA and amino acids 410-489 of VP16. The product of this construct is intended to mimic the BACE1 cleaved protein isoform of APP |
| APP/C99 |
P{UAS-APP.C99.myc.Exel}21 |
33783 |
Expresses the C99 fragment of APP with the human APP signal peptide and a C-terminal myc tag under UAS control. |
| APP/C99 |
P{UAS-APP.C99.myc.Exel}19 |
33784 |
Expresses the C99 fragment of APP with the human APP signal peptide and a C-terminal myc tag under UAS control. |
| APP/C99 |
P{UAS-APP.C99.Lcp2sp.HA.Exel}11 |
33785 |
Expresses the C99 fragment of APP with a fly signal peptide (from Lcp2) and three copies of an HA tag at the C-terminus under UAS control. |
| APP/C99 - London |
P{UAS-APP.C99.V717I.HA.Exel}9 |
33786 |
Expresses the C99 fragment of APP carrying the familial Alzheimer's 'London' mutation (V717I - numbering based on APP sequence) with the human APP signal peptide and three copies of an HA tag at the C-terminus under UAS control. |
| APP/C99 - London |
P{UAS-APP.C99.V717I.HA.Exel}3B |
34533 |
Expresses the C99 fragment of APP carrying the familial Alzheimer's 'London' mutation (V717I - numbering based on APP sequence) with the human APP signal peptide and three copies of an HA tag at the C-terminus under UAS control. |
| APP/C99 - mutant |
P{UAS-APP.C99.YIPLFL.HA.Exel}4a |
33788 |
Expresses the C99 fragment of APP with amino acids YIPLFL substituted for GVVIAT (APP amino acids 709-714) under UAS control. Construct uses the human APP signal sequence, and 3 copies of the HA tag at the C-terminus. |
| APP/C99 - mutant |
P{UAS-APP.C99.YIPLFL.HA.Exel}3 |
33787 |
Expresses the C99 fragment of APP with amino acids YIPLFL substituted for GVVIAT (APP amino acids 709-714) under UAS control. Construct uses the human APP signal sequence and has 3 copies of the HA tag at the C-terminus. |
| Stocks carrying the Abeta42 fragment of human APP |
| Abeta |
PBac{UAS-Abeta.3-42}VK00033 |
64217 |
Expresses human Abeta amino acids 3-42 under the control of UAS. |
| Abeta |
PBac{UAS-Abeta.3-42.E3A}VK00033 |
64222 |
Expresses human Abeta amino acids 3-42 with the amino acid change E3A under the control of UAS. |
| Abeta |
PBac{UAS-Abeta.11-42}VK00033 |
64218 |
Expresses human Abeta amino acids 11-42 under the control of UAS. |
| Abeta |
PBac{UAS-Abeta.11-42.E11A}VK00033 |
64221 |
Expresses human Abeta amino acids 11-42 with the amino acid change E11A under the control of UAS. |
| Abeta |
PBac{UAS-Abeta.1-43}VK00033 |
64219 |
Expresses human Abeta amino acids 1-43 under the control of UAS. |
| Abeta |
PBac{UAS-Abeta.1-42.A42D}VK00033 |
64220 |
Expresses human Abeta amino acids 1-42 with the amino acid change A42D under the control of UAS. |
| Abeta |
PBac{UAS-Abeta.1-38}VK00033 |
64214 |
Expresses human Abeta amino acids 1-38 under the control of UAS. |
| Abeta42 |
P{UAS-APP.Abeta42.B}m26a |
33770 |
Expresses the human Abeta42 fragment of APP under the control of UAS. Stock also expresses GFP under actin control in males. |
| Abeta42 |
P{UAS-APP.Abeta42.B}m26a |
33769 |
Expresses the human Abeta42 fragment of APP under the control of UAS. |
| Abeta42 |
P{UAS-Abeta1-42.G}3 |
32037 |
Expresses the 42 amino acid version of human Abeta under the control of UAS. |
| Abeta42 |
P{UAS-Abeta1-42.G}1 |
32038 |
Expresses the 42 amino acid version of human Abeta under the control of UAS. |
| Abeta42 - Arctic |
P{UAS-APP.Abeta42.E693G.VTR}8 |
33774 |
Expresses the human Abeta42 fragment of APP carrying the familial Alzheimer's 'Arctic' mutation (E693G - amino acid numbering based on APP sequence) under the control of UAS. |
| Abeta42 - Arctic |
P{UAS-APP.Abeta42.E693G.VTR}4 |
33773 |
Expresses the human Abeta42 fragment of APP carrying the familial Alzheimer's 'Arctic' mutation (E693G - amino acid numbering based on APP sequence) under the control of UAS. |
| Abeta42 - Dutch |
P{UAS-APP.Abeta42.E693Q.VTR}3 |
33776 |
Expresses the human Abeta42 fragment of APP carrying the familial Alzheimer's 'Dutch' mutation (E693Q - amino acid numbering based on APP sequence) under the control of UAS. |
| Abeta42 - Dutch |
P{UAS-APP.Abeta42.E693Q.VTR}2 |
33775 |
Expresses the human Abeta42 fragment of APP carrying the familial Alzheimer's 'Dutch' mutation (E693Q - amino acid numbering based on APP sequence) under the control of UAS. |
| Abeta42 - Flemish |
P{UAS-APP.Abeta42.A692G.VTR}6 |
33777 |
Expresses the human Abeta42 fragment of APP carrying the familial Alzheimer's 'Flemish' mutation (A692G - amino acid numbering based on APP sequence) under the control of UAS. |
| Abeta42 - Flemish |
P{UAS-APP.Abeta42.A692G.VTR}2 |
33778 |
Expresses the human Abeta42 fragment of APP carrying the familial Alzheimer's 'Flemish' mutation (A692G - amino acid numbering based on APP sequence) under the control of UAS. |
| Abeta42 - Iowa |
P{UAS-APP.Abeta42.D694N.VTR}X |
35584 |
Expresses the human Abeta42 fragment of APP carrying the familial Alzheimer's 'Iowa' mutation (D694N - amino acid numbering based on APP sequence) under the control of UAS. |
| Abeta42 - Iowa |
P{UAS-APP.Abeta42.D694N.VTR}3 |
33780 |
Expresses the human Abeta42 fragment of APP carrying the familial Alzheimer's 'Iowa' mutation (D694N - amino acid numbering based on APP sequence) under the control of UAS. |
| Abeta42 - Iowa |
P{UAS-APP.Abeta42.D694N.VTR}2 |
33779 |
Expresses the human Abeta42 fragment of APP carrying the familial Alzheimer's 'Iowa' mutation (D694N - amino acid numbering based on APP sequence) under the control of UAS. |
| Abeta42 - Italian |
P{UAS-APP.Abeta42.E693K.VTR}8 |
33781 |
Expresses the human Abeta42 fragment of APP carrying the familial Alzheimer's 'Italian' mutation (E693K - amino acid numbering based on APP sequence) under the control of UAS. |
| Abeta42 - Italian |
P{UAS-APP.Abeta42.E693K.VTR}12 |
33782 |
Expresses the human Abeta42 fragment of APP carrying the familial Alzheimer's 'Italian' mutation (E693K - amino acid numbering based on APP sequence) under the control of UAS. |
| Abeta42 and tau |
P{UAS-Abeta42.B}m26a, P{UAS-MAPT.VTR}12D |
33771 |
Expresses the human Abeta42 fragment of APP and human MAPT (tau) under the control of UAS. Stock also expresses GFP under actin control only in males and hid under heatshock control only in females. |
| Abeta42 and tau |
P{UAS-Abeta42.B}m26a, P{UAS-MAPT.VTR}12D |
33772 |
Expresses the human Abeta42 fragment of APP and human MAPT (tau) under the control of UAS. Also expresses hid under heatshock control only in males. |
| Stocks carrying human APP-like proteins, APLP1 and APLP2 |
| APP/APLP2 |
P{UAS-HsapAPLP2::HsapAPP.T:Myc}2 |
30123 |
Expresses a myc-tagged fusion of human APP and APLP2 under UAS control. |
| Fly APP-like (Appl) stocks |
| Appl |
Appl[d] |
43632 |
Null allele of Appl (deletion of the central part of the gene) |
| Appl - RNAi |
P{TRiP.JF02878}attP2 |
28043 |
Expresses double-stranded RNA for RNAi of Appl under the control of UAS. |
| Appl - RNAi |
P{TRiP.HMS01931}attP40 |
39013 |
Expresses dsRNA for RNAi of Appl (FBgn0000108) under UAS control. |
| Appl |
P{UAS-Appl.V5}3 |
63222 |
Expresses a V5-tagged APPL under the control of UAS. |
| Appl |
P{UAS-Appl.V5}1 |
63223 |
Expresses a V5-tagged APPL under the control of UAS. |
| Appl |
P{UAS-Appl.T}2 |
38403 |
Expresses full-length Appl under the control of UAS. |
| Appl |
P{UAS-Appl.sdDeltaCg}KW |
32041 |
Expresses a constitutively membrane-bound form of Appl deleted for the Go binding domain (amino acids 845-855) under the control of UAS. |
| Appl - ECD mtuant |
P{UAS-Appl.sdDeltaE1}3 |
29866 |
UAS sequences control expression of a constitutively membrane-bound form of Appl deleted for a region (amino acids 85-321) of the extracellular domain including part of the E1 domain. |
| Appl - ECD mutant |
P{UAS-Appl.sdDeltaE2}3 |
29867 |
UAS sequences control expression of a constitutively membrane-bound form of Appl deleted for a region (amino acids 449-740) of the extracellular domain including most of the E2 domain. |
| Appl - ICD mutant |
P{UAS-Appl.sdDeltaIC}2 |
29865 |
UAS sequences control expression of a constitutively membrane-bound form of Appl deleted for the intracellular domain. |
| Appl - mutant |
P{UAS-Appl.sd}2 |
29863 |
UAS sequences control Appl deleted for a cleavage site resulting in a constitutively membrane-bound protein. |
| Appl - NPTY mutant |
P{UAS-Appl.sdDeltaNPTY}3 |
29864 |
UAS sequences control expression of a constitutively membrane-bound form of Appl deleted for the NPTY internalization sequence. |
| Appl - secreted |
P{UAS-Appl.s}2 |
29862 |
Expresses a secreted form of Appl under the control of UAS. |
| Appl |
P{Appl-GAL4.G1a}1 |
32040 |
Expresses GAL4 in the larval nervous system under the control of APPL. |
| Appl |
Mi{Trojan-GAL4.0}Appl[MI11551-TG4.0] |
66900 |
Recombination Mediated Cassette Exchange of a Mi{MIC} insertion results in expression of GAL4 under the control of Appl regulatory sequences. |
| Stocks carrying human BACE1 |
| BACE1 (human) |
P{UAS-BACE1.VTR}A |
33804 |
Expresses human BACE1 under UAS control. |
| BACE1 (human) |
P{UAS-BACE1.L}2 |
29877 |
Expresses human BACE (beta-secretase) under the control of UAS. |
| Stocks carrying human FE65/APBB1 |
| Fe65 (aka APBB1) |
P{UAS-HsapAPBB1-HA}3 |
29882 |
UAS sequences control expression of human APBB1 (aka Fe65) tagged with HA. |
| Fe65 (aka APBB1) |
P{UAS-HsapAPBB1-HA}2 |
29881 |
UAS sequences control expression of human APBB1 (aka Fe65) tagged with HA. |
| Stocks carrying human HSD17B10 and Fly scu stocks |
| ERAB (aka HSD17B10) |
P{UAS-HSD17B10.Exel}1 |
33806 |
Expresses human HSD17B10 (ERAB) under UAS control. May be segregating CyO. |
| Fly par-1 stocks |
| par-1 |
par-1[k05603] |
10574 |
P{lacW} insertion into the 5' UTR of par-1 and mei-W68 |
| par-1 |
Mi{MIC}par-1[MI07146] |
55433 |
This Mi{MIC} insertion in an intron of par-1 is uncharacterized but is an unverified lethal (suggesting it may disrupt function). |
| par-1 |
P{TRiP.HMS00405}attP2 |
32410 |
Expresses dsRNA for RNAi of par-1 (FBgn0260934) under the control of UAS. |
| par-1 |
P{TRiP.GL00253}attP2 |
35342 |
Expresses dsRNA for RNAi of par-1 (FBgn0260934) under the control of UAS. |
| par-1 |
Mi{PT-GFSTF.2}par-1[MI12277-GFSTF.2] |
64452 |
Recombination Mediated Cassette Exchange of a Mi{MIC} insertion results in expression of par-1 tagged with EGFP-FlAsH-StrepII-TEV-3xFlag. |
| par-1 |
P{lacW}par-1[k06323] |
10615 |
P{lacW} insertion in the 5' UTR or second intron par-1 (depending on the transcript) |
| Fly nicastrin (nct) stocks |
| nct |
nct[J1] |
63240 |
Amino acid change results in a loss of function allele |
| nct |
nct[E3] |
63241 |
Hypomorphic allele of nct |
| nct |
nct[A7] |
41781 |
An allele of nct caused by aa change Q640stop. |
| nct |
P{TRiP.JF02648}attP2 |
27498 |
Expresses double-stranded RNA for RNAi of nicastrin under the control of UAS |
| nct |
P{TRiP.HMC04812}attP40 |
57497 |
Expresses dsRNA for RNAi of nct (FBgn0039234) under UAS control. |
| nct |
P{UAS-nct.2.myc}3 |
63215 |
Expresses myc-tagged nct under the control of UAS. |
| Fly pen-2 stocks |
| pen-2 |
P{TRiP.JF02608}attP2 |
27298 |
Expresses double-stranded RNA for RNAi of pen-2 under the control of UAS |
| pen-2 |
P{TRiP.HMC03648}attP40 |
52908 |
Expresses dsRNA for RNAi of pen-2 (FBgn0053198) under UAS control. |
| pen-2 |
P{UAS-pen-2.flag}3 |
64067 |
Expresses FLAG-tagged pen-2 under the control of UAS. |
| pen-2 |
P{UAS-pen-2.flag}2 |
63219 |
Expresses FLAG-tagged pen-2 under the control of UAS. |
| pen-2 |
P{UAS-pen-2.flag}1 |
63218 |
Expresses FLAG-tagged pen-2 under the control of UAS. |
| Stocks carrying human PSEN1 and PSEN2 |
| PSEN1 |
P{UAS-PSEN1.VTR}11 |
33811 |
Expresses human Presenilin 1 (PSEN1) isoform I-467 under the control of UAS. |
| PSEN1 |
P{UAS-PSEN1.VTR}1 |
33812 |
Expresses human Presenilin 1 (PSEN1) isoform I-467 under the control of UAS. |
| PSEN1 - M146V |
P{UAS-PSEN1.M146V.Exel}4 |
33813 |
Expresses human Presenilin 1 (PSEN1) carrying the familial Alzheimer's mutation M146V under the control of UAS. |
| PSEN1 - P267S |
P{UAS-PSEN1.P267S.Exel}1 |
33814 |
Expresses human Presenilin 1 (PSEN1) carrying the familial Alzheimer's mutation P267S under the control of UAS. |
| PSEN2 |
P{UAS-PSEN2.Exel}7b |
33817 |
Expresses human Presenilin 2 (PSEN2) under the control of UAS. |
| PSEN2 - M239V |
P{UAS-PSEN2.M239V.Exel}2b |
33815 |
Expresses human Presenilin 2 (PSEN2) carrying the familial Alzheimer's mutation M239V under the control of UAS. |
| PSEN2 - N141I |
P{UAS-PSEN2.N141I.Exel}8b |
33816 |
Expresses human Presenilin 2 (PSEN2) carrying the familial Alzheimer's mutation N141I under the control of UAS. |
| Fly Psn stocks |
| Psn lof |
Psn[143] |
8296 |
Presenilin null allele on a FRT-bearing chromosome for making clones. |
| Psn lof |
Psn[143] |
8297 |
Presenilin null allele |
| Psn |
Psn[C4] |
63238 |
Amino acid change W152stop. Mutation is predicted to result in a truncated protein ending at the beginning of the second transmembrane domain. |
| Psn |
Psn[B3] |
63239 |
Amino acid change G516E results in a loss of function allele |
| Psn lof |
Psn[9] |
8295 |
Presenilin hypomorphic allele |
| Psn |
Psn[V1] |
63237 |
Amino acid change W478stop. Mutation is predicted to result in a truncated protein ending at the beginning of the eighth transmembrane domain. |
| Psn - RNAi |
P{UAS-antisense.Psn.541}3 |
8316 |
Expresses the sequence for the 541 amino acid isoform of Psn in the antisense direction under the control of UAS. |
| Psn - RNAi |
P{UAS-antisense.Psn.541}2 |
8317 |
Expresses the sequence for the 541 amino acid isoform of Psn in the antisense direction under the control of UAS. |
| Psn - RNAi |
P{UAS-antisense.Psn.541}1 |
8318 |
Expresses the sequence for the 541 amino acid isoform of Psn in the antisense direction under the control of UAS. |
| Psn - RNAi |
P{TRiP.JF02760}attP2 |
27681 |
Expresses double-stranded RNA for RNAi of Psn under the control of UAS. |
| Psn - RNAi |
P{TRiP.HMS01843}attP40 |
38374 |
Expresses dsRNA for RNAi of Psn (FBgn0019947) under the control of UAS. |
| Psn |
P{UAS-Psn.N.myc}3 |
64046 |
Expresses Psn with an N-terminal myc-tag under the control of UAS. The tag detects both the intact holoprotein and the processed N-terminal fragment. |
| Psn |
P{UAS-Psn.N.myc}2 |
63212 |
Expresses Psn with an N-terminal myc-tag under the control of UAS. The tag detects both the intact holoprotein and the processed N-terminal fragment. |
| Psn |
P{UAS-Psn.loop.myc}3 |
63211 |
Expresses Psn with a myc-tag inserted in the cytoplasmic loop expressed under the control of UAS. The tag detects both the intact holoprotein and the processed C-terminal fragment. |
| Psn |
P{UAS-Psn.loop.myc}2 |
63210 |
Expresses Psn with a myc-tag inserted in the cytoplasmic loop expressed under the control of UAS. The tag detects both the intact holoprotein and the processed C-terminal fragment. |
| Psn |
P{UAS-Psn.541.Exel}3 |
8310 |
Expresses the wild type 541 amino acid isoform of Psn under the control of UAS. |
| Psn |
P{UAS-Psn.541.Exel}2 |
8309 |
Expresses the wild type 541 amino acid isoform of Psn under the control of UAS. |
| Psn |
P{UAS-Psn.541.Exel}1 |
8308 |
Expresses the wild type 541 amino acid isoform of Psn under the control of UAS. |
| Psn |
P{UAS-Psn.527.Exel}3 |
8306 |
Expresses the wild type 527 amino acid isoform of Psn under the control of UAS. |
| Psn |
P{UAS-Psn.527.Exel}2 |
8305 |
Expresses the wild type 527 amino acid isoform of Psn under the control of UAS. |
| Psn |
P{UAS-Psn.527.Exel}1 |
8304 |
Expresses the wild type 527 amino acid isoform of Psn under the control of UAS. |
| Psn |
P{UAS-Psn.-14}3 |
63214 |
Expresses the short form (cytoplasmic loop is 14 aa shorter than in the 'long' form) of Psn under the control of UAS. |
| Psn |
P{UAS-Psn.+14}3 |
63213 |
Expresses the long form (cytoplasmic loop is 14 aa longer than in the 'short' form) of Psn under the control of UAS. |
| Psn |
P{UAS-Psn.+14}2 |
63243 |
Expresses the long form (cytoplasmic loop is 14 aa longer than in the 'short' form) of Psn under the control of UAS. |
| Psn |
P{sev-Psn.527.Exel}3 |
8314 |
Expresses the wild type 527 amino acid isoform of Psn in the eye. |
| Psn |
P{sev-Psn.527.Exel}2 |
8315 |
Expresses the wild type 527 amino acid isoform of Psn in the eye. |
| Psn |
P{Psn.N.myc}3 |
63209 |
Expresses Psn with an N-terminal myc-tag under the control of a Psn promoter. The tag detects both the intact holoprotein and the processed N-terminal fragment. |
| Psn |
P{Psn.loop.myc}32 |
63207 |
Expresses Psn with a myc-tag inserted in the cytoplasmic loop expressed under the control of a Psn promoter. The tag detects both the intact holoprotein and the processed C-terminal fragment. |
| Psn |
P{Psn.loop.myc}3 |
63208 |
Expresses Psn with a myc-tag inserted in the cytoplasmic loop expressed under the control of a Psn promoter. The tag detects both the intact holoprotein and the processed C-terminal fragment. |
| Psn |
P{GMR-Psn.527.Exel}3 |
8319 |
Expresses the wild type 527 amino acid isoform of Psn in the eye. |
| Psn |
P{GMR-Psn.527.Exel}2 |
8320 |
Expresses the wild type 527 amino acid isoform of Psn in the eye. |
| Psn - D279A (D257A) |
P{GMR-Psn.527.D279A}3 |
8332 |
Expresses the 527 amino acid isoform of Psn with a D279A amino acid change in the eye. D279A mimics the D257A change in humans. |
| Psn - D279A (D257A) |
P{GMR-Psn.527.D279A}2 |
8333 |
Expresses the 527 amino acid isoform of Psn with a D279A amino acid change in the eye. D279A mimics the D257A change in humans. |
| Psn - D447A (D385A) |
P{UAS-Psn.527.D447A}3 |
8323 |
Expresses the 541 amino acid isoform of Psn with a D447A amino acid change under the control of UAS. D447A mimics the D385A change in humans. |
| Psn - D447A (D385A) |
P{UAS-Psn.527.D447A}2 |
8322 |
Expresses the 541 amino acid isoform of Psn with a D447A amino acid change under the control of UAS. D447A mimics the D385A change in humans. |
| Psn - D447A (D385A) |
P{UAS-Psn.527.D447A}1 |
8321 |
Expresses the 541 amino acid isoform of Psn with a D447A amino acid change under the control of UAS. D447A mimics the D385A change in humans. |
| Psn - D447A (D385A) |
P{GMR-Psn.527.D447A}3 |
8335 |
Expresses the 527 amino acid isoform of Psn with a D279A amino acid change in the eye. D279A mimics the D257A change in humans. |
| Psn - D447A (D385A) |
P{GMR-Psn.527.D447A}2 |
8334 |
Expresses the 527 amino acid isoform of Psn with a D279A amino acid change in the eye. D279A mimics the D257A change in humans. |
| Psn - D447A (D385A) |
P{GMR-Psn.527.D447A}1 |
8336 |
Expresses the 527 amino acid isoform of Psn with a D279A amino acid change in the eye. D279A mimics the D257A change in humans. |
| Psn - D477A/exon9 |
P{UAS-Psn.527.deltaE9.D447A}3 |
8328 |
Expresses the 527 amino acid isoform of Psn with the equivalent of human Psn exon 9 deleted and replaced with a Cys and a D447A amino acid change under UAS control. D447A mimics the D385A change in humans. |
| Psn - D477A/exon9 |
P{UAS-Psn.527.deltaE9.D447A}2 |
8327 |
Expresses the 527 amino acid isoform of Psn with the equivalent of human Psn exon 9 deleted and replaced with a Cys and a D447A amino acid change under UAS control. D447A mimics the D385A change in humans. |
| Psn - D477A/exon9 |
P{UAS-Psn.527.deltaE9.D447A}1 |
8329 |
Expresses the 527 amino acid isoform of Psn with the equivalent of human Psn exon 9 deleted and replaced with a Cys and a D447A amino acid change under UAS control. D447A mimics the D385A change in humans. |
| Psn - D477A/exon9 |
P{GMR-Psn.527.deltaE9.D447A}2 |
8330 |
Expresses the 527 amino acid isoform of Psn with the equivalent of human Psn exon 9 deleted and replaced with a Cys and a D447A amino acid change in the eye. D447A mimics the D385A change in humans. |
| Psn - D477A/exon9 |
P{GMR-Psn.527.deltaE9.D447A}1 |
8331 |
Expresses the 527 amino acid isoform of Psn with the equivalent of human Psn exon 9 deleted and replaced with a Cys and a D447A amino acid change in the eye. D447A mimics the D385A change in humans. |
| Psn - M255V (M239V) |
P{UAS-Psn.541.M255V}3 |
8313 |
Expresses the 541 amino acid isoform of Psn with a M255V amino acid change under the control of UAS. M255V mimics the M239V change in humans. |
| Psn - M255V (M239V) |
P{UAS-Psn.541.M255V}2 |
8312 |
Expresses the 541 amino acid isoform of Psn with a M255V amino acid change under the control of UAS. M255V mimics the M239V change in humans. |
| Psn - M255V (M239V) |
P{UAS-Psn.541.M255V}1 |
8311 |
Expresses the 541 amino acid isoform of Psn with a M255V amino acid change under the control of UAS. M255V mimics the M239V change in humans. |
| Psn - N157I (N141I) |
P{UAS-Psn.541.N157I.Exel}3 |
8584 |
Expresses the 541 amino acid isoform of Psn with a N157I amino acid change under the control of UAS. N157I mimics the N141I change in humans. |
| Psn - N157I (N141I) |
P{UAS-Psn.541.N157I.Exel}1 |
8307 |
Expresses the 541 amino acid isoform of Psn with a N157I amino acid change under the control of UAS. N157I mimics the N141I change in humans. |
| Psn - exon9 mutant |
P{UAS-Psn.527.deltaE9}3 |
8337 |
Expresses the 527 amino acid isoform of Psn with the equivalent of human Psn exon 9 deleted and replaced with a Cys under UAS control. |
| Psn - exon9 mutant |
P{UAS-Psn.527.deltaE9}2 |
8338 |
Expresses the 527 amino acid isoform of Psn with the equivalent of human Psn exon 9 deleted and replaced with a Cys under UAS control. |
| Psn - exon9 mutant |
P{GMR-Psn.527.deltaE9}3 |
8326 |
Expresses the 527 amino acid isoform of Psn with the equivalent of human Psn exon 9 deleted and replaced with a Cys in the eye. |
| Psn - exon9 mutant |
P{GMR-Psn.527.deltaE9}2 |
8325 |
Expresses the 527 amino acid isoform of Psn with the equivalent of human Psn exon 9 deleted and replaced with a Cys in the eye. |
| Psn - exon9 mutant |
P{GMR-Psn.527.deltaE9}1 |
8324 |
Expresses the 527 amino acid isoform of Psn with the equivalent of human Psn exon 9 deleted and replaced with a Cys in the eye. |
| Stocks carrying human Tau (MAPT) and fly tau stocks |
| tau |
tau[MR22] |
9530 |
An imprecise excision of P{EP}tau[EP3203] has deleted 62 kb removing almost all of the tau gene including the microtubule binding domain. The mini-white of the P{EP} is still present. |
| tau |
TI{TI}tau[KO] |
64782 |
Homologous replacement of tau exons with miniwhite. |
| tau |
P{TRiP.HMS02042}attP40 |
40875 |
Expresses dsRNA for RNAi of tau (FBgn0051057) under UAS control. |
| tau |
P{TRiP.HM05101}attP2 |
28891 |
Expresses double-stranded RNA for RNAi of tau under the control of UAS. |
| tau |
Mi{PT-GFSTF.0}tau[MI03440-GFSTF.0] |
60199 |
Recombination Mediated Cassette Exchange of a Mi{MIC} insertion results in expression of tau tagged with EGFP-FlAsH-StrepII-TEV-3xFlag. |
| tau (human) |
P{UAS-Tau.wt}7B |
51363 |
Expresses the 2N4R isoform of human tau (MAPT) under the control of UAS. |
| tau (human) |
P{UAS-Tau.wt}1.13 |
51362 |
Expresses the 2N4R isoform of human tau (MAPT) under the control of UAS. |
| tau (human) |
P{UAS-MAPT.VTR}12D |
33819 |
Expresses human MAPT (tau) under the control of UAS. |
| tau (human) |
P{UAS-MAPT.B}31o |
33820 |
Expresses human MAPT (tau) under the control of UAS. |
| tau (human) |
P{UAS-MAPT.A}59A |
181 |
Expresses human Microtubule-associated protein tau under the control of UAS. |
| tau (human) |
P{UAS-hMAPT.Z}attP40 |
64388 |
Expresses human MAPT under UAS control. |
| tau (human) |
P{UAS-hMAPT.HA}attP40 |
64389 |
Expresses human MAPT protein with a C-terminal HA tag under UAS control. |
| tau (human) |
P{GMR-MAPT.EGFP.J}2 |
51368 |
Expresses the 2N4R isoform of human tau (MAPT with EGFP fused to the C term under the control of GMR in the eye. |
| tau (human) |
P{GMR-htau.Ex}3 |
51361 |
Expresses the 2N4R isoform of human tau (MAPT) in the eye under the control of GMR. |
| tau (human) |
P{GMR-htau.Ex}1.1 |
51373 |
Expresses the 2N4R isoform of human tau (MAPT) in the eye under the control of GMR. |
| tau (human) |
P{GMR-htau.Ex}1.1 |
51360 |
Expresses the 2N4R isoform of human tau (MAPT) in the eye under the control of GMR. |
| tau (MAPT, bovine) |
P{Mhc-tauGFP}2 |
38460 |
Expresses GFP-tagged tau under the control of Mhc. |
| tau (MAPT, bovine) |
P{Mhc-tauGFP}1 |
53736 |
Expresses GFP-tagged tau under the control of Mhc. |
| tau (MAPT, bovine) |
P{Mhc-tauGFP}1 |
53739 |
Expresses GFP-tagged tau under the control of Mhc. |
| tau |
P{EP}tau[G4714] |
63271 |
This P{EP} insertion in the non-coding first exon of tau is uncharacterized but is oriented such that it may overexpress tau in the presence of GAL4. |
| tau (human) |
P{UAS-Tau.S2A}1.62 |
51365 |
Expresses the 2N4R isoform of human tau (MAPT) with mutations at two sites, S262A and S356A (PAR-1 phosphorylation sites), under the control of UAS. |
| tau (human) |
P{UAS-Tau.S2A}1.33 |
51364 |
Expresses the 2N4R isoform of human tau (MAPT) with mutations at two sites, S262A and S356A (PAR-1 phosphorylation sites), under the control of UAS. |
| tau (human) |
P{UAS-Tau.S11A}1.2 |
51366 |
Expresses the 2N4R isoform of human tau (MAPT) with Ser to Ala changes at 11 sgg-phosphorylated residues (S46A, T50A, S199A, T202A, T205A, T212A, S214A, T231A, S235A, S396A and S404A) under the control of UAS. |
| tau (human) |
P{GMR-MAPT.V337M}2 |
51369 |
Expresses the 2N4R isoform of human tau (MAPT) with a V337M change under the control of GMR in the eye. |
| tau (human) |
P{GMR-MAPT.V337M}10 |
51367 |
Expresses the 2N4R isoform of human tau (MAPT) with a V337M change under the control of GMR in the eye. |
| tau (human) |
P{GMR-htau.P301L}x |
51377 |
Expresses human tau (MAPT) with a P301L change under the control of GMR in the eye. |
| Stocks carrying multiple constructs |
| Abeta42 and tau |
P{UAS-Abeta42.B}m26a, P{UAS-MAPT.VTR}12D |
33771 |
Expresses the human Abeta42 fragment of APP and human MAPT (tau) under the control of UAS. Stock also expresses GFP under actin control only in males and hid under heatshock control only in females. |
| Abeta42 and tau |
P{UAS-Abeta42.B}m26a, P{UAS-MAPT.VTR}12D |
33772 |
Expresses the human Abeta42 fragment of APP and human MAPT (tau) under the control of UAS. Also expresses hid under heatshock control only in males. |
| APP and BACE1 |
P{UAS-BACE1.Exel}7b, P{UAS-APP.695.Exel}1 |
33797 |
Expresses human BACE1 and the 695 amino acid isoform of human APP under the control of UAS. Homozygotes may be present. |
| APP and BACE1 |
P{UAS-APP695-N-myc}TW6, P{UAS-BACE1.Exel}1b |
33798 |
Expresses human BACE1 and an N-terminally myc-tagged 695 amino acid isoform of human APP under the control of UAS. |
| APP and tau |
P{UAS-APP.C99.myc.Exel}21, P{UAS-MAPT.VTR}31K |
33803 |
Expresses the C99 fragment of APP with the human APP signal peptide and a C-terminal myc tag and human MAPT (tau) under UAS control. |
| APP and tau |
P{UAS-APP.C99.myc.Exel}19, P{UAS-MAPT.VTR}12B |
33801 |
Expresses the C99 fragment of APP with the human APP signal peptide and a C-terminal myc tag and human MAPT (tau) under UAS control. |
| APP and tau |
P{UAS-APP.695.Exel}3, P{UAS-MAPT.VTR}31K |
33802 |
Expresses human MAPT (tau) and the 695 amino acid isoform of human APP under the control of UAS, VTR. |
| APP, BACE1 and tau |
P{UAS-MAPT.VTR}54, P{UAS-APP.695.Exel}3, P{UAS-BACE1.Exel}9a |
33799 |
Expresses human MAPT (tau), human BACE1, and the 695 amino acid isoform of human APP under the control of UAS. |
| APP, BACE1 and tau |
P{UAS-APP.695.Exel}3, P{UAS-BACE1.Exel}9a, P{UAS-MAPT.VTR}31 |
33800 |
Expresses human MAPT (tau), human BACE1, and the 695 amino acid isoform of human APP under the control of UAS. |